CRON News and Press, Cronos Group Inc. From 02/26/24

A recent legal opinion has challenged the U.S. Drug Enforcement Administration’s (“DEA”) stance, suggesting that international treaties related to drugs should not hinder cannabis rescheduling as recommended by the U.S. Department of Health and Human Services (“HHS&#...

2024-02-23 11:47:18 ET More on cannabis stocks Cronos Group: Flush With Cash And Trading Below Book Value Canopy Growth Corporation (CGC) Q3 2024 Earnings Call Transcript Aurora Cannabis Inc. (ACB) Q3 2024 Earnings Call Transcript Aurora Cannabis names Simona...

2024-02-19 13:30:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Before investing in equities, there needs to be a clearly defined objective. Some investors prefer blue-chip dividend stocks for regular cash inflows, while others seek multibagger growth s...

TORONTO, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2023 fourth quarter and full-year earnings conference call on Thursday, February 29, 2024 at 8:30 a.m. ET. Cronos’ senior management...

2024-02-13 08:00:33 ET Top Canadian Cannabis Stocks for Mid-February 2024 The Canadian cannabis sector remains a hotbed of activity, drawing attention from investors globally. With legalization trends expanding, Canadian marijuana stocks are at the forefront. This week, several comp...

A recently amended measure, HB 698, advanced by a Virginia Assembly subcommittee, seeks to permit existing medical cannabis dispensaries and certain small businesses to commence recreational marijuana sales in January next year , with more retailers expected to be licensed by year-end. A medic...

2024-02-11 03:25:29 ET Summary Cronos Group has a cash position of $840 million, which is over 100% of its market cap, and zero debt. The company is trading at a discount to book value, with a potential 36% upside if the stock trades in line with book value. Cronos Group's ope...

2024-02-07 12:16:36 ET More on U.S. MSOs Alan Brochstein On Rescheduling Overexcitement, MSOs, Canada And The Burden Of 280E Curaleaf Is A Bad Cannabis Investment Cresco Labs At The Crossroads: Strategic Agility In A Transforming Cannabis Landscape Cresco Lab...

2024-02-06 12:25:57 ET More on cannabis ETFs MSOS: Investors Should Exit This ETF MSOS: Cannabis Sector Consolidating Under The Radar, Looking Constructive (Technical Analysis) Cannabis Investors - What You Should Know Cannabis companies higher after Biden pa...

A lawsuit filed against the state of Mississippi by a medical cannabis dispensary owner has been dismissed. The lawsuit challenged Mississippi’s laws, which the plaintiff said placed restrictions on marijuana businesses by forbidding them from placing advertisements on a majority of medi...